Please enable JavaScript to continue using this application.

Compare $COGT vs $DNTH | Chartloom

Compare

$COGT vs $DNTH

Cogent Biosciences Inc · Dianthus Therapeutics Inc

COGT

Cogent Biosciences Inc

DNTH

Dianthus Therapeutics Inc

Compare $COGT vs $DNTH

Comparing Cogent Biosciences Inc and Dianthus Therapeutics Inc

COGTCogent Biosciences Inc

DNTHDianthus Therapeutics Inc

COGTCogent Biosciences Inc

Market cap

$5.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.59x

Rev growth (TTM)

—

YTD performance

-10.8%

52W performance

99.0%

FCF yield

-5.8%

DNTHDianthus Therapeutics Inc

Market cap

$4.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3,009.80x

Rev growth (TTM)

-60.8%

YTD performance

107.6%

52W performance

137.0%

FCF yield

-3.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COGT

DNTH

Detailed metrics comparison

COGT

Cogent Biosciences Inc

DNTH

Dianthus Therapeutics Inc

Market Cap

COGT$5.30B

DNTH$4.50B

Enterprise Value

COGT$5.34B

DNTH$4.39B

Price

COGT$31.00

DNTH$82.37

P/E Ratio

COGTN/A

DNTHN/A

P/S Ratio

COGT232.42x

DNTH2,365.11x

EV/Sales

COGT234.24x

DNTH2,307.05x

EV/EBITDA

COGT0.00x

DNTH0.00x

P/B Ratio

COGT10.11x

DNTH4.21x

P/FCF Ratio

COGTN/A

DNTHN/A

EV/FCF

COGT-17.27x

DNTH-28.21x

PEG Ratio

COGTN/A

DNTHN/A

Forward P/E (NTM)

COGTN/A

DNTHN/A

Forward P/S (NTM)

COGT24.59x

DNTH3,009.80x

Revenue (TTM)

COGT$0

DNTH$2M

Revenue Growth (YoY)

COGTN/A

DNTH-60.8%

Forward Rev Growth

COGT2636.5%

DNTH-5.4%

Gross Margin (TTM)

COGT0.0%

DNTH0.0%

Operating Margin (TTM)

COGT0.0%

DNTH0.0%

EBITDA Margin (TTM)

COGT0.0%

DNTH-11434.9%

Net Margin (TTM)

COGT0.0%

DNTH-10097.0%

FCF Margin (TTM)

COGTN/A

DNTH-8178.0%

Net Income (TTM)

COGT$-332M

DNTH$-192M

FCF (TTM)

COGT$-309M

DNTH$-156M

EPS (TTM)

COGT-$1.94

DNTH-$3.43

ROE (TTM)

COGT-7257.0%

DNTH-2253.0%

ROA (TTM)

COGT-4865.0%

DNTH-2155.0%

ROIC (TTM)

COGT-5402.0%

DNTH-2253.0%

Cash

COGT$181M

DNTH$111M

Debt

COGT$223M

DNTH$0

Net Cash/Debt

COGT$-42M

DNTH$111M

Current Ratio (TTM)

COGT13.57x

DNTH26.10x

Quick Ratio (TTM)

COGT13.36x

DNTH25.80x

Debt/Equity (TTM)

COGT0.42x

DNTH0.00x

Debt/Assets (TTM)

COGT0.0%

DNTH0.0%

Interest Coverage (TTM)

COGTN/A

DNTHN/A

Net Debt/EBITDA (TTM)

COGT0.00x

DNTH0.00x

Beta

COGT0.34

DNTH1.99

52W Performance

COGT99.0%

DNTH137.0%

YTD Performance

COGT-10.8%

DNTH107.6%

% from 52W High

COGT-29.1%

DNTH-30.1%

% from 52W Low

COGT125.0%

DNTH155.6%

Asset Turnover (TTM)

COGT0.36x

DNTH0.00x

FCF Yield (TTM)

COGT-5.8%

DNTH-3.5%

Earnings Yield (TTM)

COGT-6.3%

DNTH-4.3%

Dividend Yield (TTM)

COGTN/A

DNTHN/A

Rule of 40

COGT0.0

DNTH-8,238.8

EV/GP/RG

COGTN/A

DNTHN/A

Ticker research

View COGT research View DNTH research

Metric	COGT Cogent Biosciences Inc	DNTH Dianthus Therapeutics Inc
Market & Valuation
Market Cap	$5.30B	$4.50B
Enterprise Value	$5.34B	$4.39B
Price	$31.00	$82.37
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	2,365.11x
EV/Sales	234.24x	2,307.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	4.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-28.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	3,009.80x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-60.8%
Forward Rev Growth	2636.5%	-5.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-11434.9%
Net Margin (TTM)	0.0%	-10097.0%
FCF Margin (TTM)	N/A	-8178.0%
Net Income (TTM)	$-332M	$-192M
FCF (TTM)	$-309M	$-156M
EPS (TTM)	-$1.94	-$3.43
ROE (TTM)	-7257.0%	-2253.0%
ROA (TTM)	-4865.0%	-2155.0%
ROIC (TTM)	-5402.0%	-2253.0%
Financial Health
Cash	$181M	$111M
Debt	$223M	$0
Net Cash/Debt	$-42M	$111M
Current Ratio (TTM)	13.57x	26.10x
Quick Ratio (TTM)	13.36x	25.80x
Debt/Equity (TTM)	0.42x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	1.99
52W Performance	99.0%	137.0%
YTD Performance	-10.8%	107.6%
% from 52W High	-29.1%	-30.1%
% from 52W Low	125.0%	155.6%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-5.8%	-3.5%
Earnings Yield (TTM)	-6.3%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-8,238.8
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View DNTH research

Valuation

P/S Ratio

COGT

232.42x

DNTH

2,365.11x

EV/FCF

DNTH

-28.21x

COGT

-17.27x

Growth & revenue

Revenue Growth TTM

DNTH

-60.8%

Forward Revenue Growth

COGT

2636.5%

DNTH

-5.4%

Profitability & performance

Gross Margin

COGT

0.0%

DNTH

0.0%

ROE

DNTH

-2253.0%

COGT

-7257.0%

FCF Yield %

DNTH

-3.5%

COGT

-5.8%

52-Week Performance

DNTH

137.0%

COGT

99.0%

Detailed metrics comparison

COGT

Cogent Biosciences Inc

DNTH

Dianthus Therapeutics Inc

Market Cap

COGT$5.30B

DNTH$4.50B

Enterprise Value

COGT$5.34B

DNTH$4.39B

Price

COGT$31.00

DNTH$82.37

P/E Ratio

COGTN/A

DNTHN/A

P/S Ratio

COGT232.42x

DNTH2,365.11x

EV/Sales

COGT234.24x

DNTH2,307.05x

EV/EBITDA

COGT0.00x

DNTH0.00x

P/B Ratio

COGT10.11x

DNTH4.21x

P/FCF Ratio

COGTN/A

DNTHN/A

EV/FCF

COGT-17.27x

DNTH-28.21x

PEG Ratio

COGTN/A

DNTHN/A

Forward P/E (NTM)

COGTN/A

DNTHN/A

Forward P/S (NTM)

COGT24.59x

DNTH3,009.80x

Revenue (TTM)

COGT$0

DNTH$2M

Revenue Growth (YoY)

COGTN/A

DNTH-60.8%

Forward Rev Growth

COGT2636.5%

DNTH-5.4%

Gross Margin (TTM)

COGT0.0%

DNTH0.0%

Operating Margin (TTM)

COGT0.0%

DNTH0.0%

EBITDA Margin (TTM)

COGT0.0%

DNTH-11434.9%

Net Margin (TTM)

COGT0.0%

DNTH-10097.0%

FCF Margin (TTM)

COGTN/A

DNTH-8178.0%

Net Income (TTM)

COGT$-332M

DNTH$-192M

FCF (TTM)

COGT$-309M

DNTH$-156M

EPS (TTM)

COGT-$1.94

DNTH-$3.43

ROE (TTM)

COGT-7257.0%

DNTH-2253.0%

ROA (TTM)

COGT-4865.0%

DNTH-2155.0%

ROIC (TTM)

COGT-5402.0%

DNTH-2253.0%

Cash

COGT$181M

DNTH$111M

Debt

COGT$223M

DNTH$0

Net Cash/Debt

COGT$-42M

DNTH$111M

Current Ratio (TTM)

COGT13.57x

DNTH26.10x

Quick Ratio (TTM)

COGT13.36x

DNTH25.80x

Debt/Equity (TTM)

COGT0.42x

DNTH0.00x

Debt/Assets (TTM)

COGT0.0%

DNTH0.0%

Interest Coverage (TTM)

COGTN/A

DNTHN/A

Net Debt/EBITDA (TTM)

COGT0.00x

DNTH0.00x

Beta

COGT0.34

DNTH1.99

52W Performance

COGT99.0%

DNTH137.0%

YTD Performance

COGT-10.8%

DNTH107.6%

% from 52W High

COGT-29.1%

DNTH-30.1%

% from 52W Low

COGT125.0%

DNTH155.6%

Asset Turnover (TTM)

COGT0.36x

DNTH0.00x

FCF Yield (TTM)

COGT-5.8%

DNTH-3.5%

Earnings Yield (TTM)

COGT-6.3%

DNTH-4.3%

Dividend Yield (TTM)

COGTN/A

DNTHN/A

Rule of 40

COGT0.0

DNTH-8,238.8

EV/GP/RG

COGTN/A

DNTHN/A

Ticker research

View COGT research View DNTH research

Metric	COGT Cogent Biosciences Inc	DNTH Dianthus Therapeutics Inc
Market & Valuation
Market Cap	$5.30B	$4.50B
Enterprise Value	$5.34B	$4.39B
Price	$31.00	$82.37
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	2,365.11x
EV/Sales	234.24x	2,307.05x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	4.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-28.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	3,009.80x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-60.8%
Forward Rev Growth	2636.5%	-5.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-11434.9%
Net Margin (TTM)	0.0%	-10097.0%
FCF Margin (TTM)	N/A	-8178.0%
Net Income (TTM)	$-332M	$-192M
FCF (TTM)	$-309M	$-156M
EPS (TTM)	-$1.94	-$3.43
ROE (TTM)	-7257.0%	-2253.0%
ROA (TTM)	-4865.0%	-2155.0%
ROIC (TTM)	-5402.0%	-2253.0%
Financial Health
Cash	$181M	$111M
Debt	$223M	$0
Net Cash/Debt	$-42M	$111M
Current Ratio (TTM)	13.57x	26.10x
Quick Ratio (TTM)	13.36x	25.80x
Debt/Equity (TTM)	0.42x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	1.99
52W Performance	99.0%	137.0%
YTD Performance	-10.8%	107.6%
% from 52W High	-29.1%	-30.1%
% from 52W Low	125.0%	155.6%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-5.8%	-3.5%
Earnings Yield (TTM)	-6.3%	-4.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-8,238.8
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View DNTH research